According to the most recent financial data from March 2026, the EPS for the trailing twelve months is $0.62. Astrana Health's EPS for 2025 amounted to $0.46, marking a drop from $0.91 in 2024. During the quarterly period ending on Mar 31, 2026, ASTH's EPS stood at $0.3.
Astrana Health had an annual EPS of $0.46, indicating a drop of 49.5% from $0.91 in 2024. The quarterly per-share earnings for the period ending Mar 31, 2026, was $0.3, indicating a 114.3% increase from the same quarter last year. ASTH's 12-month EPS stands at $0.62 as of March 2026. Astrana Health's annual EPS in 2024 stood at $0.91, a 30% decrease year-over-year.
Astrana Health has registered an increase in EPS of 114.3% during the last 12 months (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of -22.8% per year. Astrana Health had an average annual EPS growth rate of -14.9% during the last 5 years.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| NHC National Healthcare Corp | 23.48 | 17.2% | 74.5% | 23.1% |
| ASTH Astrana Health Inc. | 61.02 | -49.5% | -22.8% | -14.9% |
| INNV InnovAge Holding Corp | N/A | -37.5% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.